Skip to content
Saturday 29 August 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE · FR
MorningWire

European business, markets and politics

FTSE 100
10,824.26
+0.29%
DAX
26,569.99
+0.77%
CAC 40
8,401.18
+0.98%
STOXX 50
6,485.67
+0.95%
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
More
GermanyFranceEU InstitutionsCompetitionPublic AffairsBankingTechnologyEnergy
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
  • DE
Monday 02 September 2019 2:07 pm  |  Updated:  Monday 02 September 2019 3:23 pm

Allen & Overy’s US merger talks with O’Melveny & Myers collapse

By: James Booth

Add as a preferred source on Google
The FTSE 100 opened flat this morning but the FTSE 250 of midcap companies jumped amid hopes that the UK could still do a Brexit deal with the EU.

Magic Circle firm Allen & Overy’s longrunning merger talks with US firm O’Melveny & Myers have collapsed, the firm said today.

In a statement, the firm said:  “Allen & Overy and O’Melveny & Myers have held discussions about a possible combination and, despite agreeing that there were some compelling synergies between us and that it was sensible to explore a possible deal in some detail, we have mutually decided not to continue these discussions. Both firms have developed a great deal of mutual respect and expect to remain in close contact in the service of our shared clients. As we move ahead, we wish each other continued success.

“Building our presence in the US remains the highest priority for Allen & Overy and we will significantly increase our immediate focus on lateral individual and team hires, while remaining open to considering opportunities for larger combinations that may arise in the future.”

Read more: How would City law fare in another downturn?

O’Melveny said: “O’Melveny has concluded that the firm’s best course is to continue executing on its strategic plan—which has led to an unmatched culture, deep client partnerships, and record financial performances.”

Sources told industry website Legal Week, which first reported the news, that the plummeting pound had made it difficult for the two firms to come to terms.

“Foreign exchange rate volatility and a reduction in US interest rates affect how any deal gets valued,” a source said. “It made it too difficult to agree a valuation of each firm, and how financial integration and pay would work as a result.”

When news of the talks emerged in April 2018, the pound was trading at $1.41, today it is plumbing $1.20 as fears of a no-deal Brexit hit investor confidence.

Read more

Astrazeneca share price tumbles on $400bn megamerger talks

Astrazeneca headquarters with logo, reflecting commitment to reduce US medicine prices after Trump administration pressure

Read more: City’s elite Magic Circle law firms under pressure from expansion of US entrants

A merger between the pair would have created a £2bn legal giant and given A&O more heft in the competitive US market.

US firms have successfully built out London offices in recent years, taking on the Magic Circle firms on their home turf.

In contrast, the Magic Circle have struggled to sustain credible practices stateside, hampered by the higher profitability typical at US firms.

The firm’s management have previously said they anticipate the emergence of a handful of leading global law firms and that building a sizeable US practice was key to being part of that group.

In its results for 2018, O’Melveny posted revenue of $800m and profit per equity partner (Pep) of $2.2m.

In 2018-19, A&O grew revenue five per cent to £1.62bn and grew Pep one per cent to £1.6m.

Read more

Astrazeneca explores $400bn megadeal with US rival 

AstraZeneca building exterior with logo, glass facade, UK flag, and wildflowers in foreground.

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Categories

  • Legal

Trending Articles

  • Pensioners to hand over bank statements in government benefits crackdown

  • Jamie Carragher: HMRC petitions for Sky Sports star to be declared bankrupt

  • Brewdog founder James Watt hits out at ‘total silence’ over new venture

  • Jamie Vardy bags Bundesliga rights as he steps up streaming war with Neville and Lineker

  • Lloyds Bank and Halifax users unable to use app in latest outage

More from Morning Wire

  • Astrazeneca share price tumbles on $400bn megamerger talks

    Investing
    Astrazeneca headquarters with logo, reflecting commitment to reduce US medicine prices after Trump administration pressure
  • Astrazeneca explores $400bn megadeal with US rival 

    Markets
    AstraZeneca building exterior with logo, glass facade, UK flag, and wildflowers in foreground.
  • IPO tweaks are welcome, but London’s market needs root and branch reform

    Opinion
    Busy London Stock Exchange trading floor in the 1980s with brokers at hexagonal trading posts.
  • As it happened: UK stocks cool after Astrazeneca drags; Trump and Iran clash over peace talks

    FTSE 100 Live
    Donald Trump speaking at a desk, gesturing with hands, wearing a dark suit and red tie.
  • Prothena Reports Second Quarter 2026 Financial Results and Business Highlights

    Business Wire
  • Revolut founder’s wealth set to balloon amid talks of share award at $500bn valuation

    Fintech
    Revolut CEO Nik Storonsky speaking at a business conference, wearing a suit and tie, addressing financial innovation.
  • Multiplier Raises $35 Million Series B to Build a New Model for Professional Services

    Business Wire
  • Private equity-backed advisory firm acquires specialist music boutique

    Advisory
    Nowadays, headliners are less of a major part of the festival experience
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • EU Institutions
  • Europe

Business

  • Markets
  • Business
  • Economy
  • Regulation
  • Competition
  • Public Affairs

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook